Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb or Sink?

With a market cap of $233.7 billion, Abbott Laboratories (ABT) is a leading global healthcare company engaged in the discovery, development, manufacturing, and sale of a broad portfolio of medical products. The North Chicago, Illinois-based company’s operations span four key segments: diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. 

Over the past year, ABT shares have soared 22.3%, surpassing the broader S&P 500 Index ($SPX), which has gained 20.1%. Moreover, ABT stock has risen 18.7% on a YTD basis, compared to SPX's 8.6% rise.